Jushi Holdings Inc.

C$0.63As of Sun 8 Nov 2026, 12:00 UTC

CSE:JUSHHealthcare

Country Canada

PE (Fwd) —

TSR 7Y CAGR (14.01%)

Div yield —

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 1.04

PE TTM —

TSR TTM (29.21%)

Mkt cap C$125.8M

ROIC 7.42%

SE Grade™

—

Value

—

Quality

Moat

1Y Price

Reference

$1.20

—

90.61%

—

Buy 1|3|0|0|0

TTM

FYE 31 Dec USD

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

276.5

Revenue$M

—

284.3

269.4

257.5

262.9

279.9

(2.57%)

—

Revenue growth%

—

(5.22)

(4.42)

2.09

6.45

(4.42)

—

44.24

Gross margin%

—

33.59

43.14

45.94

43.35

44.36

43.24

—

3.07

Operating margin%

—

(21.35)

1.53

3.45

0.83

3.34

1.18

—

(19.98)

Net margin%

—

(71.17)

(24.16)

(18.94)

(26.09)

(19.42)

(25.13)

—

P/E ratio (avg)x

—

42.68

EV/EBITx

—

94.59

41.99

172.4

37.87

94.59

—

4.87

FCF yield (avg)%

—

(17.47)

(11.94)

13.83

0.41

5.86

(5.77)

—

1.56

FCF margin%

—

(27.54)

(5.22)

6.55

0.16

1.82

(2.53)

—

(0.078)

FCF / Net incomex

—

0.387

0.216

(0.346)

—

0.105

—

7.42

ROIC%

—

(17.73)

1.36

3.80

1.22

8.75

1.29

—

Return on equity%

—

(427.95)

(317.21)

—

(372.58)

—

(13.00)

Return on assets%

—

(38.22)

(14.05)

(11.08)

(16.24)

(13.21)

(15.14)

—

(0.28)

EPS$

—

(0.99)

(0.33)

(0.25)

(0.35)

(0.28)

—

EPS growth%

—

66.26

25.23

(40.59)

21.53

25.23

—

(0.78)

Bookvalue per sh$

—

0.23

(0.03)

(0.26)

(0.59)

(0.86)

—

0.02

FCF per share$

—

(0.38)

(0.07)

0.09

—

0.03

(97.43%)

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

199.7

Shares (diluted)M

—

204.2

194.8

195.2

◌195.2

(1.50%)

—

Buyback yield%

—

4.63

(0.20)

(0.02)

◌—

(0.02)

—

(1.929)

D/E ratiox

—

6.794

(47.95)

(5.397)

(2.544)

(1.772)

(3.970)

—

362.2

Enterprise value$M

—

743.2

390.6

373.5

375.1

354.2

(20.39%)

—

100

194.5

LT debt$M

—

180.6

126.0

183.4

199.2

194.5

3.33%

—

100

Peers (US$87.68M)

Cap (US$)

Ascend Wellness…

110.5M

—

Organogenesis Holdings…

105.6M

—

Cumberland Pharmaceuti…

78.21M

—

Kyongbo Pharmaceutical…

88.04M

23.65x

Capital

TTM

10Y

Leveragex

6.650

8.122

EBIT/Intx

0.205

0.082

Own earn%

—

Sh yield%

—

(0.02)

Owners

Insiders/Inst%

9.82

11.91

Short interest%

—

SBC / revenue%

0.97

Record

10Y

Profitable years

0/4

Revenue growth years

1/3

EPS growth years

2/3

Dividend streakyrs

Op margin range%

−21–3

$1 testx

—

Incr. ROIC%

—

Jushi Holdings Inc. engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

$262.9M

(2.57%)

1.00×

Cost of revenue

$148.9M

(7.60%)

0.85×

Operating expenses

$111.8M

(10.54%)

0.77×

Asset mix

Trend

Other

65.16%

Goodwill & intangibles

29.15%

Cash and investments

5.69%

Reinvestment returns

5Y median

Trend

Reinvestment rate

(383.75%)

Return on capital

1.29%

Spread over hurdle

n/m